Tempus AI EBITDA 2025-2024 | TEM
- Tempus AI EBITDA for the quarter ending June 30, 2024 was $M, a NAN% increase year-over-year.
- Tempus AI EBITDA for the twelve months ending June 30, 2024 was $0M, a NAN% increase year-over-year.
- Tempus AI 2023 annual EBITDA was $0B, a NAN% decline from 2022.
- Tempus AI 2022 annual EBITDA was $0B, a NAN% decline from .
- Tempus AI annual EBITDA was $0B, a NAN% decline from .
Tempus AI Annual EBITDA (Millions of US $) |
|
---|---|
2023 | $ |
2022 | $ |
Tempus AI Quarterly EBITDA (Millions of US $) |
|
---|---|
2024-06-30 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $8.309B | $0.000B |
Tempus AI Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics. Tempus AI Inc. is based in CHICAGO. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $42.008B | 22.60 |
Inspire Medical Systems (INSP) | United States | $6.038B | 1124.89 |
Hims & Hers Health (HIMS) | United States | $3.817B | 222.13 |
Axonics (AXNX) | United States | $3.550B | 0.00 |
10x Genomics (TXG) | United States | $2.732B | 0.00 |
Enovis (ENOV) | United States | $2.437B | 17.66 |
Azenta (AZTA) | United States | $2.415B | 137.17 |
IRhythm Technologies (IRTC) | United States | $2.276B | 0.00 |
Privia Health (PRVA) | United States | $2.162B | 150.67 |
Omnicell (OMCL) | United States | $1.979B | 65.18 |
Clover Health Investments (CLOV) | United States | $1.403B | 0.00 |
Schrodinger (SDGR) | United States | $1.364B | 0.00 |
Phreesia (PHR) | United States | $1.313B | 0.00 |
Standard BioTools (LAB) | United States | $0.713B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.641B | 0.00 |
Definitive Healthcare (DH) | United States | $0.520B | 441.00 |
Health Catalyst (HCAT) | United States | $0.503B | 0.00 |
Talkspace (TALK) | United States | $0.341B | 0.00 |
Butterfly Network (BFLY) | United States | $0.336B | 0.00 |
Pulmonx (LUNG) | United States | $0.325B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.244B | 0.00 |
TruBridge (TBRG) | United States | $0.179B | 13.12 |
American Well (AMWL) | United States | $0.142B | 0.00 |
P3 Health Partners (PIII) | United States | $0.140B | 0.00 |
Augmedix (AUGX) | United States | $0.116B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.099B | 0.00 |
Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
111 (YI) | China | $0.064B | 0.00 |
HeartBeam (BEAT) | United States | $0.061B | 0.00 |
Zepp Health (ZEPP) | China | $0.060B | 0.00 |
SHL Telemedicine (SHLT) | Israel | $0.052B | 0.00 |
CareCloud (CCLD) | United States | $0.042B | 0.00 |
Movano (MOVE) | United States | $0.037B | 0.00 |
Outset Medical (OM) | United States | $0.032B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
MSP Recovery (LIFW) | United States | $0.022B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.022B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.018B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.015B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
Precipio (PRPO) | United States | $0.010B | 0.00 |
Predictive Oncology (POAI) | United States | $0.005B | 0.00 |
HeartSciences (HSCS) | United States | $0.005B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.003B | 0.00 |
Syra Health (SYRA) | United States | $0.002B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |